Question 1

What is Gleevec?

Accepted Answer

Gleevec, also known by its generic name imatinib, belongs to a class of medications called kinase inhibitors. It works by blocking the action of a specific abnormal protein that signals cancer cells to multiply.

By targeting these proteins, the medication helps to stop or slow the progression of the disease. It is designed to interfere with the signaling pathways that allow cancer cells to grow and survive.

Question 2

What is Gleevec used for?

Accepted Answer

Gleevec is used to treat:

Chronic myeloid leukemia

Acute lymphoblastic leukemia

Gastrointestinal stromal tumor

and others.

Question 3

How does Gleevec work?

Accepted Answer

Targeting Cancer Growth

Gleevec belongs to a class of drugs known as tyrosine kinase inhibitors. Unlike traditional chemotherapy, which affects all rapidly dividing cells, Gleevec is a targeted therapy designed to interfere with specific proteins that contribute to cancer growth.

How It Blocks Cancer Signals

In certain types of cancer, such as Philadelphia chromosome-positive chronic myeloid leukemia (CML), the body produces an abnormal protein called BCR-ABL. This protein acts like a switch that is stuck in the "on" position, signaling white blood cells to multiply uncontrollably. Gleevec works by:

Binding to the protein: The drug attaches to the abnormal protein in cancer cells.

Interrupting the signal: By blocking the protein's ability to transmit signals, Gleevec prevents the cells from receiving the message to grow and divide.

Slowing progression: This action helps stop or slow the spread of cancer cells and may lead to the death of existing cancer cells.

Gleevec also targets other proteins, including KIT and PDGFR. By blocking these specific enzymes, the medication can also treat other conditions, such as gastrointestinal stromal tumors (GIST), by preventing the signals that cause those tumors to grow.

Question 4

What are the active ingredients in Gleevec?

Accepted Answer

The active ingredient in Gleevec is imatinib .

Question 5

What are the side effects of Gleevec?

Accepted Answer

Common side effects of Gleevec may include:

Nausea

Diarrhea

Muscle cramps

and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Gleevec?

Accepted Answer

Gleevec belongs to the tyrosine kinase inhibitor drug class.

Question 7

What is the dosage of Gleevec and how do I take it?

Accepted Answer

How to Take Gleevec

Gleevec is a tablet taken by mouth. It should be taken with a meal and a large glass of water to reduce the risk of stomach irritation. Depending on the condition being treated, it is usually prescribed to be taken once or twice a day.

Administration Instructions

Swallowing: Tablets should generally be swallowed whole.

Alternative Method: For patients who have difficulty swallowing tablets, the medication can be dissolved in a glass of water or apple juice. The tablet should be stirred into the liquid until it has completely broken down, and the mixture should be swallowed immediately.

Consistency: It is best to take the medication at the same time each day to maintain consistent levels in the bloodstream.

Missed Dose

If a dose is missed, skip the missed dose and take the next dose at the regularly scheduled time. Do not take an extra dose or double the dose to make up for the one that was missed. If you are unsure what to do after missing a dose, contact a healthcare provider for guidance.

Storage and Handling

The medication should be stored at room temperature in a dry place. Because Gleevec can be absorbed through the skin and lungs, individuals who are pregnant or may become pregnant should avoid handling the tablets or breathing in any dust from crushed tablets.

Question 8

Is Gleevec safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Gleevec (imatinib) can cause harm to an unborn baby if taken during pregnancy. Clinical reports and animal studies indicate that exposure to this medication may lead to birth defects or pregnancy loss. Individuals who are pregnant or planning to become pregnant should discuss the potential risks and benefits of treatment with their healthcare provider.

Healthcare providers typically recommend that females who can become pregnant use effective birth control during treatment and for at least 14 days after the final dose. If a patient becomes pregnant while taking this medication, they should notify their doctor immediately.

Breastfeeding

Imatinib and its active components are known to pass into human breast milk. Because of the risk of serious side effects in a nursing infant, breastfeeding is not recommended while taking Gleevec. Most guidelines suggest waiting at least one month after the last dose before resuming breastfeeding.

Question 9

What forms and strengths does Gleevec come in?

Accepted Answer

Gleevec is supplied as film-coated tablets. This medication is taken orally.

The tablets are designed to be swallowed whole with a meal and a large glass of water to help prevent irritation. For patients who are unable to swallow the tablets, they may be dissolved in a glass of water or apple juice before consumption.

Question 10

What is the FDA approval status of Gleevec?

Accepted Answer

FDA Approval and Indications

Gleevec (imatinib) is a prescription medication that received its initial approval from the U.S. Food and Drug Administration (FDA) in 2001. It is approved to treat several specific cancers and blood-related conditions in both adults and children.

Approved indications include:

Certain phases of chronic myeloid leukemia (CML).

Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Myelodysplastic or myeloproliferative diseases (MDS/MPD) associated with specific gene re-arrangements.

Aggressive systemic mastocytosis (ASM) without certain genetic mutations.

Hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL).

Gastrointestinal stromal tumors (GIST) that are KIT-positive.

Dermatofibrosarcoma protuberans (DFSP) that cannot be removed by surgery, has returned, or has spread.

Safety Monitoring

The FDA monitors the safety of Gleevec through various reporting systems. The medication does not currently have a boxed warning, which is the FDA's most serious type of warning, nor does it require a Risk Evaluation and Mitigation Strategy (REMS) program.

In 2018, the FDA identified a potential safety signal regarding the risk of aneurysm (a bulge in an artery wall) and artery dissection (a tear in an artery wall) associated with the use of imatinib. The FDA continues to evaluate adverse event reports to determine if further regulatory action or labeling changes are necessary.

Question 11

What should I know about Gleevec and cost?

Accepted Answer

Factors Influencing Cost

The price of Gleevec can vary based on several elements:

Insurance Coverage: Most health insurance plans cover imatinib, the generic version of Gleevec. However, insurance companies may require prior authorization before they agree to pay for the brand-name version.

Generic Availability: A generic version of Gleevec, called imatinib, is available. Generic medications usually cost significantly less than brand-name drugs while providing the same therapeutic benefits.

Pharmacy and Dosage: The specific pharmacy used and the dosage strength prescribed by a doctor will also impact the final cost.

Financial Assistance Programs

There are resources available to help manage the cost of this medication:

Patient Assistance: Some manufacturers offer programs to provide the medication at a lower cost or for free to patients who meet specific financial criteria.

Copay Cards: For patients with commercial insurance, copay savings cards may be available to reduce out-of-pocket expenses.

Support Organizations: Certain non-profit organizations offer financial support to help patients cover the costs of cancer treatments.

Gleevec

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?